In amyotrophic lateral sclerosis (ALS), the exogenous temporal triggers that result in initial motor neuron death are not understood. Overactivation and consequent accelerated loss of vulnerable motor neurons is one theory of disease initiation. The vulnerability of motor neurons in response to chronic peripheral nerve hyperstimulation was tested in the SOD1 G93A rat model of ALS. A novel in vivo technique for peripheral phrenic nerve stimulation was developed via intra-diaphragm muscle electrode implantation at the phrenic motor endpoint. Chronic bilateral phrenic nerve hyperstimulation in SOD1 G93A rats accelerated disease progression, including shortened lifespan, hastened motor neuron loss and increased denervation at diaphragm neuromuscular junctions. Hyperstimulation also resulted in focal decline in adjacent forelimb function. These results show that peripheral phrenic nerve hyperstimulation accelerates cell death of vulnerable spinal motor neurons, modifies both temporal and anatomical onset of disease, and leads to involvement of disease in adjacent anatomical regions in this ALS model. Published by Elsevier Inc.
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Introduction
Potential exogenous triggers or risk factors for motor neuron degeneration and the development of amyotrophic lateral sclerosis (ALS) have been hypothesized, including infectious etiologies such as viruses (Mattson, 2004) , toxic or heavy metal exposures (Sutedja et al., 2008b) , central nervous system or peripheral nerve trauma (Mitsumoto et al., 1998 ), occupation (Sutedja et al., 2008a , exercise and body habitus (Chen et al., 2008) , amongst others. More recently, the hunt for disease modifying genes has also been undertaken (Ravits and Traynor, 2008) . However, little is known about the factors that influence the anatomical site of disease onset in ALS. Why does disease start with limb onset in one patient, while it begins with speech, swallowing or breathing problems in another? It is also not appreciated which factors play a role in the anatomical progression of disease to adjacent regions of the neuraxis. For example, patients with weakness in one leg generally develop weakness in the other leg prior to the development of speech or swallowing abnormalities. This pattern is also manifested in the caudal-to-rostral disease progression observed in mutant human SOD1-expressing transgenic rodent models.
The vast majority of ALS cases are sporadic, while approximately 10% are familial. Twenty percent of familial cases are linked to various point mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene on chromosome 21 (Rosen et al., 1993) . Transgenic mice (Bruijn et al., 1997; Gurney et al., 1994; Wong et al., 1995) and rats (Howland et al., 2002; Matsumoto et al., 2006; Nagai et al., 2001) carrying mutant human SOD1 genes (G93A, G37R, G86R, G85R) have been generated, and, despite the existence of other animal models of motor neuron loss, are currently the most highly used models of the disease.
ALS patients ultimately succumb to disease approximately 2-5 years following diagnosis because of respiratory compromise due to loss of phrenic motor neuron innervation of the diaphragm. Furthermore, the extent of respiratory involvement has been reported as a major prognostic factor (Haverkamp et al., 1995) . Interventions targeting respiratory function have resulted in impressive, albeit incomplete, efficacy on ALS patient survival (Lo Coco et al., 2006) . We have also shown cervical motor neuron loss, phrenic nerve axonal loss, diaphragm atrophy and progressive reduction of phrenic nerve compound muscle action potential amplitudes in SOD1 G93A rats Neurobiology of Disease 39 (2010) 252-264 
